Skip to main content

Table 1 Characteristics of patients included in the study

From: Characterisation of microbiota in saliva, bronchoalveolar lavage fluid, non-malignant, peritumoural and tumour tissue in non-small cell lung cancer patients: a cross-sectional clinical trial

  Total Upper lobe T Lower lobe T p
No. of patients 18 10 8  
Male/female 13/5 8/2 5/3  
Age (years) 68 ± 8 65 ± 9 72 ± 6 0.061
BMI 25 ± 3 25 ± 4 25 ± 3 0.859
T in upper/middle/lower lobe 10/2/6 10/0/0 0/2/6  
ADC/SCC/carcinoid 11/5/2 6/2/2 5/3/0  
Stage I/II/III 8/2/8 5/2/3 3/0/5  
Tumour size (cm) 3.7 ± 2.3 3.6 ± 2.4 3.9 ± 2.4 1
Smoker/ex-smoker/never-smoker 2/14/2 0/9/1 2/5/1  
Pack-year (smokers, ex-smokers) 31 ± 20 31 ± 21 33 ± 20 0.823
FEV1 (% of expected value) 98 ± 11 95 ± 8 101 ± 14 0.408
DLCO (% of expected value) 74 ± 16 81 ± 13 64 ± 16 0.034
FEV1/FVC (% of expected value) 96 ± 10 95 ± 11 98 ± 10 0.630
Final no. of analysed samples
 Saliva 17 10 7  
 BAL 15 8 7  
 LUNG.DP 17 10 7  
 LUNG.PT 14 9 5  
 LUNG.T 16 9 7  
  1. ADC adenocarcinoma, BAL bronchoalveolar lavage fluid, BMI body mass index, DLCO diffusing capacity of the lung for carbon monoxide, FEV1 forced expiratory volume per second, FVC forced vital capacity, LUNG.DP non-malignant tissue, LUNG.PT peritumoural tissue, LUNG. T tumour, SCC squamous cell carcinoma, T tumour